参·考·文·献

参·考·文·献

[1]Gioia S,Nardelli S,Ridola L,et al.Causes and management of non-cirrhotic portal hypertension[J].Curr Gastroenterol Rep,2020,22(12):56.

[2]Da BL,Surana P,Kapuria D,et al.Portal pressure in noncirrhoticportal hypertension:to measure or not to measure[J].Hepatology,2019,70(6):2228-2230.

[3]Lee H,Ainechi S,Singh M,et al.Histological spectrum of idiopathic noncirrhotic portal hypertension in liver biopsies from dialysispatients[J].Int J Surg Pathol,2015,23(6):439-446.

[4]Schouten JN,Garcia-Pagan JC,Valla DC,et al.Idiopathic Noncirrhotic portal hypertension[J].Hepatology,2011,54(3):1071-1081.

[5]Siramolpiwat S,Seijo S.Idiopathic non-cirrhotic portal hypertension[J].J Rare Dis Res Treat,2016,1(3):10-16.(https://www.daowen.com)

[6]Schouten JN,Verheij J.Idiopathic non-cirrhotic portal hypertension:a review[J].Orphanet J Rare Diss,2015,10:67.

[7]Rajesh S,Mukund A,Sureka B,et al.Non-cirrhotic portal hypertension:an imaging review hypertension:an imaging review[J].Abdominal Radiology(New York),2018,43(8):1991-2010.

[8]European Association for the Study of the Liver.EASL clinical practice guidelines:Vascular diseases of the liver[J].J Hepatol,2016,64(1):179-202.

[9]Siramolpiwat S,Seijo S,Miquel R,et al.Idiopathic portal hypertension:natural history and long-term outcome[J].Hepatology,2014,59(6):2276-2285.

[10]夏亮,丁凯阳,骨髓增殖性肿瘤患者JAK2V617F基因突变与血栓栓塞相关性研究[J].中华血液学杂志,2009,31:590-593.